KRAS and cancer: PANC-1 cells that harbour oncogenic KRas but are independent of this oncogene18, as well as the KRas wild-type-expressing BxPC-3 cancer cell line exhibited minor growth inhibitory effects on doxycycline-induced shRNA knockdown of PDEδ.